← Back to Search

Peer Navigation for Prostate Cancer

N/A

Waitlist Available

Led By Jackie Bender, PhD

Research Sponsored by University Health Network, Toronto

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Has been diagnosed with local, locally advanced or stable metastatic PC

Must not have

Is not willing to be randomized

Is receiving palliative care

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 years

Awards & highlights

No Placebo-Only Group

Summary

This trial will test whether a new cancer patient navigation program, which pairs patients with trained peer navigators, can improve quality of life, social support and health care service use for men with prostate cancer.

Who is the study for?

This trial is for Canadian men who've recently finished prostate cancer treatment within the last 3 months, can read and speak English, and have an email or are willing to create one. It's not for those with advanced metastatic disease, receiving palliative care, or unwilling to be randomly assigned.

What is being tested?

The study tests a web-based peer navigation program where men with prostate cancer receive guidance from trained peers online. The goal is to see if this support improves their quality of life and health management compared to usual care plus website information access.

What are the potential side effects?

Since this trial involves a support program rather than medication, traditional side effects like you'd expect from drugs aren't applicable. However, participants may experience emotional impacts from discussing sensitive health issues.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My prostate cancer is not spreading rapidly.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am not open to being randomly assigned to a treatment group.

Select...

I am receiving care focused on relieving symptoms and improving quality of life.

Select...

My cancer has spread to other parts of my body.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Patient Activation at 3 months

Secondary study objectives

Change in Anxiety

Change in Depression

Change in Fear of Cancer Recurrence

+5 more

Other study objectives

Intervention cost

Quality-adjusted life year

Total healthcare costs

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: InterventionExperimental Treatment1 Intervention

Participants assigned to the intervention arm will receive the True North Peer Navigation intervention.

Group II: Active Waitlist ControlExperimental Treatment1 Intervention

Participants assigned to the control arm will receive usual care and access to an online health resource library. After completion of the study, they will receive the True North Peer Navigation intervention.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Peer navigation

2016

Completed Phase 4

~220

0 / 4Eligibility criteria met